Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway

CONTEXT: Shenmai Injection (SMI) is usually used to treat atherosclerotic coronary heart disease and viral myocarditis in China. However, the effect of SMI on multidrug resistance has not been reported. OBJECTIVE: To investigate the reversal effect of SMI in adriamycin (ADR) resistant breast cancer...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharm Biol
Main Authors: Yang, Lin, Zhang, Chengda, Chen, Jiaoting, Zhang, Sheng, Pan, Guixuan, Xin, Yanfei, Lin, Lin, You, Zhenqiang
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7170370/
https://ncbi.nlm.nih.gov/pubmed/32251615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13880209.2020.1742167
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados